Ubiquilin 2 antibody (AA 555-624)
(11 references)-
- Target See all Ubiquilin 2 (UBQLN2) Antibodies
- Ubiquilin 2 (UBQLN2)
-
Binding Specificity
- AA 555-624
-
Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This Ubiquilin 2 antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA, Immunofluorescence (IF)
- Purpose
- Mouse monoclonal antibody raised against a partial recombinant UBQLN2.
- Sequence
- PNQQFIQQMV QALAGANAPQ LPNPEVRFQQ QLEQLNAMGF LNREANLQAL IATGGDINAA IERLLGSQPS
- Cross-Reactivity
- Human, Mouse, Rat
- Characteristics
- Antibody Reactive Against Recombinant Protein.
- Immunogen
- UBQLN2 (NP_038472, 555 a.a. ~ 624 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
- Clone
- 5F5
- Isotype
- IgG2a
-
anti-Ubiquilin 2 (UBQLN2) (AA 1-150) antibody
UBQLN2 Reactivity: Human WB, IHC, IF Host: Rabbit Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) (N-Term) antibodyUBQLN2 Reactivity: Human WB, IHC (p) Host: Rabbit Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) (AA 473-542) antibodyUBQLN2 Reactivity: Human ELISA, IHC, IF Host: Rabbit Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) antibodyUBQLN2 Reactivity: Human, Mouse WB, IF Host: Rabbit Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) (AA 33-126) antibodyUBQLN2 Reactivity: Human WB, ELISA, ICC, IHC (p), IHC (fro) Host: Rabbit Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) antibodyUBQLN2 Reactivity: Human, Mouse WB, ELISA, IHC Host: Rabbit Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) (AA 555-624) antibodyUBQLN2 Reactivity: Human WB, ELISA Host: Mouse Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) (C-Term) antibodyUBQLN2 Reactivity: Human WB Host: Rabbit Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) (C-Term) antibodyUBQLN2 Reactivity: Human, Mouse, Rat WB, ELISA Host: Rabbit Polyclonal unconjugated
anti-Ubiquilin 2 (UBQLN2) (AA 81-130) antibodyUBQLN2 Reactivity: Human, Rat, Rabbit, Cow, Dog, Monkey WB Host: Rabbit Polyclonal unconjugated
-
- Application Notes
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Buffer
- In 1x PBS, pH 7.4
- Handling Advice
- Aliquot to avoid repeated freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
-
-
: "Marked Involvement of the Striatal Efferent System in TAR DNA-Binding Protein 43 kDa-Related Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis." in: Journal of neuropathology and experimental neurology, (2016) (PubMed).
: "Drosha inclusions are new components of dipeptide-repeat protein aggregates in FTLD-TDP and ALS C9orf72 expansion cases." in: Journal of neuropathology and experimental neurology, Vol. 74, Issue 4, pp. 380-7, (2015) (PubMed).
: "Differential recruitment of UBQLN2 to nuclear inclusions in the polyglutamine diseases HD and SCA3." in: Neurobiology of disease, Vol. 82, pp. 281-8, (2015) (PubMed).
: "Ubiquilin-1 immunoreactivity is concentrated on Hirano bodies and dystrophic neurites in Alzheimer's disease brains." in: Neuropathology and applied neurobiology, Vol. 39, Issue 7, pp. 817-30, (2014) (PubMed).
: "Lower motor neuron involvement in TAR DNA-binding protein of 43 kDa-related frontotemporal lobar degeneration and amyotrophic lateral sclerosis." in: JAMA neurology, Vol. 71, Issue 2, pp. 172-9, (2014) (PubMed).
: "C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking." in: Human molecular genetics, Vol. 23, Issue 13, pp. 3579-95, (2014) (PubMed).
: "C9ORF72 repeat-associated non-ATG-translated polypeptides are distributed independently of TDP-43 in a Japanese patient with c9ALS." in: Neuropathology and applied neurobiology, Vol. 40, Issue 6, pp. 783-8, (2014) (PubMed).
: "Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion." in: Acta neuropathologica, Vol. 125, Issue 2, pp. 289-302, (2013) (PubMed).
: "Progressive amnestic dementia, hippocampal sclerosis, and mutation in C9ORF72." in: Acta neuropathologica, Vol. 126, Issue 4, pp. 545-54, (2013) (PubMed).
: "Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion." in: Acta neuropathologica, Vol. 123, Issue 6, pp. 825-39, (2012) (PubMed).
: "p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS." in: Acta neuropathologica, Vol. 122, Issue 6, pp. 691-702, (2011) (PubMed).
-
: "Marked Involvement of the Striatal Efferent System in TAR DNA-Binding Protein 43 kDa-Related Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis." in: Journal of neuropathology and experimental neurology, (2016) (PubMed).
-
- Target
- Ubiquilin 2 (UBQLN2)
- Alternative Name
- UBQLN2 (UBQLN2 Products)
- Synonyms
- ALS15 antibody, CHAP1 antibody, DSK2 antibody, N4BP4 antibody, PLIC2 antibody, Chap1 antibody, Dsk2 antibody, HRIHFB2157 antibody, Plic-2 antibody, Plic2 antibody, RGD1563566 antibody, UBQLN2 antibody, ubiquilin 2 antibody, UBQLN2 antibody, Ubqln2 antibody
- Background
-
Full Gene Name: ubiquilin 2
Synonyms: CHAP1,CHAP1/DSK2,Dsk2,HRIHFB2157,LIC-2,N4BP4,PLIC-2,PLIC2,RIHFB2157 - Gene ID
- 29978
- NCBI Accession
- NM_013444
-
